Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Conference Call to discuss the Company''s Q3/ 9M- FY24 Results01-02-2024
01-02-2024
Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31, 2023, Interim Dividend, If Any, For The FY 2023-24 And Other Business Matters, If Any.
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 ,inter alia, to consider and approve Audited Financial Results for the quarter and nine months ended December 31, 2023, Interim Dividend, if any, for the FY 2023-24 and other business matters, if any.30-01-2024
Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 202308-01-2024
Aarti Pharmalabs Ltd - 543748 - Intimation Of Grant Of Options Under APL Performance Stock Option Plan 2023
Intimation of Grant of Options under APL Performance Stock Option Plan 202304-01-2024
Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window
Intimation of closure of Trading Window28-12-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Formal Inauguration of Research & Development Laboratory (R&D-III) at Nerul, Navi Mumbai18-12-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Conference Call for Q2 FY24 Financial Results held on November 9, 202313-11-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings Conference Call of Financial Results for Q2/ H1 FY2409-11-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Audited Financial Results for Quarter and Half year ended September 30, 202309-11-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q2 FY24 Results Presentation08-11-2023